Rubicon Research Private Limited is recalling 11,664 bottles of Metoprolol Tartrate Tablets USP (25mg), distributed by TruPharma, LLC. The recall was issued because metal fragments were found in the tablets. This medication is typically used to treat high blood pressure and chest pain; consumers should check their prescription bottles to see if they have the affected lot number and expiration date.
Ingesting metal fragments in a tablet can cause physical injury to the throat, stomach, or intestinal lining. No reports of injuries or adverse events have been confirmed in connection with this recall.
You have 2 options:
Distributed by TruPharma, LLC; Manufactured by Rubicon Research Private Limited.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.